Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study.

Bernan AP, Santos AGV

Open source

DOI
10.7759/cureus.c418
Published
2026 Mar
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.c418,
  title = {Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study.},
  author = {Bernan AP and Santos AGV},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.c418},
  url = {https://doi.org/10.7759/cureus.c418}
}

RIS

TY  - JOUR
TI  - Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study.
AU  - Bernan AP
AU  - Santos AGV
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.c418
UR  - https://doi.org/10.7759/cureus.c418
ER  - 

APA

AP, B., & AGV, S. (2026). Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study.. Cureus. https://doi.org/10.7759/cureus.c418

Source records